$ZIOP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ZIOPHARM ONCOLOGY INC. Get notifications about new insider transactions in ZIOPHARM ONCOLOGY INC for free.

Page: 1 2 3 4 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Weis Holger	Director	Option Exercise	A	4.31	150,000	646,500	150,000
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Weis Holger	Director	Option Exercise	A	4.31	31,250	134,688	31,250
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Weis Holger	Director	Grant	A	0.00	4,167	0	70,167	66 K to 70.2 K (+6.31 %)
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Vieser Jaime	Director	Option Exercise	A	4.31	150,000	646,500	150,000
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Vieser Jaime	Director	Option Exercise	A	4.31	31,250	134,688	31,250
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Vieser Jaime	Director	Grant	A	0.00	4,167	0	605,321	601.2 K to 605.3 K (+0.69 %)
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Thistle Mary	Director	Option Exercise	A	4.31	150,000	646,500	150,000
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Thistle Mary	Director	Option Exercise	A	4.31	37,500	161,625	37,500
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Thistle Mary	Director	Grant	A	0.00	5,000	0	5,000	0 to 5 K
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Postma Robert W	Director	Option Exercise	A	4.31	150,000	646,500	150,000
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Postma Robert W	Director	Option Exercise	A	4.31	18,750	80,813	18,750
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Postma Robert W	Director	Grant	A	0.00	2,500	0	1,181,362	1.2 M to 1.2 M (+0.21 %)
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Huang James	Director	Option Exercise	A	4.31	62,500	269,375	62,500
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Huang James	Director	Grant	A	0.00	8,333	0	8,333	0 to 8.3 K
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	BUCHI J KEVIN	Director	Option Exercise	A	4.31	31,250	134,688	31,250
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	BUCHI J KEVIN	Director	Grant	A	0.00	4,167	0	4,167	0 to 4.2 K
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Bowden Christopher	Director	Option Exercise	A	4.31	31,250	134,688	31,250
May 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Bowden Christopher	Director	Grant	A	0.00	4,167	0	4,167	0 to 4.2 K
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Option Exercise	A	4.31	236,250	1,018,238	236,250
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Grant	A	0.00	31,500	0	231,016	199.5 K to 231 K (+15.79 %)
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	Chief Legal Officer ...	Option Exercise	A	4.31	326,250	1,406,138	326,250
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	Chief Legal Officer ...	Grant	A	0.00	43,500	0	176,819	133.3 K to 176.8 K (+32.63 %)
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Hagen Heidi	Interim CEO	Option Exercise	A	4.31	675,000	2,909,250	675,000
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Hagen Heidi	Interim CEO	Grant	A	0.00	90,000	0	122,119	32.1 K to 122.1 K (+280.21 %)
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Option Exercise	A	4.31	381,188	1,642,920	381,188
Mar 08 2021	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Grant	A	0.00	50,825	0	257,238	206.4 K to 257.2 K (+24.62 %)
Jan 12 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Sell	S	3.12	27,894	87,029	199,516	227.4 K to 199.5 K (-12.27 %)
Jan 12 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Sell	S	3.09	18,020	55,682	63,965	82 K to 64 K (-21.98 %)
Jan 12 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Sell	S	3.12	26,500	82,680	133,319	159.8 K to 133.3 K (-16.58 %)
Jan 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Sell	S	2.72	21,620	58,806	206,413	228 K to 206.4 K (-9.48 %)
Jan 06 2021	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	President and CEO	Sell	S	2.71	105,693	286,428	1,799,280	1.9 M to 1.8 M (-5.55 %)
Oct 13 2020	ZIOP	ZIOPHARM ONCOLOGY ...	BUCHI J KEVIN	Director	Option Exercise	A	2.76	146,190	403,484	146,190
Jul 22 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Huang James	Director	Option Exercise	A	3.43	119,178	408,781	119,178
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Shukla Sath	EVP, Chief Financia ...	Option Exercise	A	4.21	123,900	521,619	123,900
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Shukla Sath	EVP, Chief Financia ...	Grant	A	0.00	80,500	0	80,500	0 to 80.5 K
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	President	Option Exercise	A	4.21	123,900	521,619	123,900
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	President	Grant	A	0.00	80,500	0	275,778	195.3 K to 275.8 K (+41.22 %)
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Grant	A	0.00	18,000	0	81,985	64 K to 82 K (+28.13 %)
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Option Exercise	A	4.21	90,800	382,268	90,800
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Grant	A	0.00	59,100	0	159,819	100.7 K to 159.8 K (+58.68 %)
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Option Exercise	A	4.21	82,600	347,746	82,600
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Grant	A	0.00	53,700	0	228,033	174.3 K to 228 K (+30.80 %)
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Option Exercise	A	4.21	264,200	1,112,282	264,200
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Grant	A	0.00	171,700	0	1,904,973	1.7 M to 1.9 M (+9.91 %)
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Option Exercise	A	4.21	82,600	347,746	82,600
Jan 31 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Grant	A	0.00	53,700	0	227,410	173.7 K to 227.4 K (+30.91 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Tarriff Scott	Director	Option Exercise	A	4.72	50,562	238,653	50,562
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Pagan Douglas W.	Director	Option Exercise	A	4.72	25,281	119,326	25,281
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Pagan Douglas W.	Director	Payment of Exercise	F	4.72	20,054	94,655	35,943	56 K to 35.9 K (-35.81 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Pagan Douglas W.	Director	Grant	A	0.00	15,890	0	55,997	40.1 K to 56 K (+39.62 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	President	Sell	S	4.55	22,394	101,893	195,278	217.7 K to 195.3 K (-10.29 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Option Exercise	A	4.72	48,000	226,560	48,000
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Sell	S	4.55	21,570	98,144	63,985	85.6 K to 64 K (-25.21 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Hagen Heidi	Director	Grant	A	0.00	31,780	0	32,119	339 to 32.1 K (+9,374.63 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Sell	S	4.55	16,853	76,681	100,719	117.6 K to 100.7 K (-14.33 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Ezickson Elan	Director	Payment of Exercise	F	4.72	40,107	189,305	71,887	112 K to 71.9 K (-35.81 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Ezickson Elan	Director	Grant	A	0.00	31,780	0	111,994	80.2 K to 112 K (+39.62 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	De Groot Eleanor	EVP, GM Cell Therap ...	Sell	S	4.55	24,890	113,250	174,333	199.2 K to 174.3 K (-12.49 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Buck Jill	EVP, GM Gene Therap ...	Sell	S	4.55	27,923	127,050	173,710	201.6 K to 173.7 K (-13.85 %)
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Braunstein Scott	Director	Grant	A	0.00	31,780	0	31,780	0 to 31.8 K
Jan 03 2020	ZIOP	ZIOPHARM ONCOLOGY ...	Bowden Christopher	Director	Option Exercise	A	4.72	50,562	238,653	50,562
Dec 31 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Option Exercise	M	2.24	44,642	99,998	487,171
Dec 31 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Sell	S	4.88	110,694	540,187	1,733,273	1.8 M to 1.7 M (-6.00 %)
Dec 31 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Buy	M	2.24	44,642	99,998	1,843,967	1.8 M to 1.8 M (+2.48 %)
Nov 27 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Option Exercise	M	2.85	11,667	33,251	0
Nov 27 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Sell	S	5.25	11,667	61,252	85,555	97.2 K to 85.6 K (-12.00 %)
Nov 27 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Buy	M	2.85	11,667	33,251	97,222	85.6 K to 97.2 K (+13.64 %)
Oct 29 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Bowden Christopher	Director	Option Exercise	A	4.26	94,031	400,572	94,031
Jul 24 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Shukla Sath	EVP, Chief Financia ...	Option Exercise	A	5.60	400,000	2,240,000	400,000
Jun 17 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Hagen Heidi	Director	Option Exercise	A	5.22	93,922	490,273	93,922
May 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Option Exercise	M	0.70	15,000	10,500	0
May 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Buy	M	0.70	15,000	10,500	398,050	383.1 K to 398.1 K (+3.92 %)
May 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Option Exercise	M	0.70	15,000	10,500	0
May 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Buy	M	0.70	15,000	10,500	398,050	383.1 K to 398.1 K (+3.92 %)
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Option Exercise	A	2.24	58,536	131,121	58,536
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Grant	A	0.00	37,122	0	85,555	48.4 K to 85.6 K (+76.65 %)
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Option Exercise	A	2.24	185,391	415,276	185,391
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Grant	A	0.00	117,572	0	117,572	0 to 117.6 K
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Option Exercise	A	2.24	531,813	1,191,261	531,813
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	2.24	165,178	369,999	1,799,325	2 M to 1.8 M (-8.41 %)
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Grant	A	0.00	446,428	0	1,964,503	1.5 M to 2 M (+29.41 %)
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Grant	A	0.00	337,266	0	1,518,075	1.2 M to 1.5 M (+28.56 %)
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	President	Option Exercise	A	2.24	250,733	561,642	250,733
Jan 08 2019	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	President	Grant	A	0.00	159,010	0	217,672	58.7 K to 217.7 K (+271.06 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Tarriff Scott	Director	Option Exercise	A	1.87	126,700	236,929	126,700
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Pagan Douglas W.	Director	Option Exercise	A	1.87	63,350	118,465	63,350
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Pagan Douglas W.	Director	Grant	A	0.00	40,107	0	40,107	0 to 40.1 K
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Payment of Exercise	F	1.87	9,334	17,455	48,433	57.8 K to 48.4 K (-16.16 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Payment of Exercise	F	1.66	13,100	21,746	57,767	70.9 K to 57.8 K (-18.49 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Lafond Kevin G	SVP, Treasurer & CA ...	Payment of Exercise	F	1.66	17,667	29,327	70,867	88.5 K to 70.9 K (-19.96 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Ezickson Elan	Director	Grant	A	0.00	80,214	0	80,214	0 to 80.2 K
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	1.87	16,156	30,212	1,180,809	1.2 M to 1.2 M (-1.35 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	1.66	26,178	43,455	1,196,965	1.2 M to 1.2 M (-2.14 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	1.66	42,920	71,247	1,223,143	1.3 M to 1.2 M (-3.39 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Option Exercise	A	1.87	126,700	236,929	126,700
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Payment of Exercise	F	1.66	4,315	7,163	383,050	387.4 K to 383.1 K (-1.11 %)
Jan 02 2019	ZIOP	ZIOPHARM ONCOLOGY ...	Braunstein Scott	Director	Option Exercise	A	1.87	126,700	236,929	126,700
Oct 09 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	130,849	0	0
Oct 09 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	130,849	0	0
Sep 28 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,295	0	130,849
Sep 20 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Ezickson Elan	Director	Option Exercise	A	3.00	50,000	150,000	50,000
Sep 20 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Braunstein Scott	Director	Option Exercise	A	3.00	50,000	150,000	50,000
Aug 31 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,282	0	129,554
Jul 31 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,270	0	128,272
Jun 29 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,257	0	127,002
Jun 04 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,245	0	125,745
May 24 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	4.41	123,333	543,899	1,266,063	1.4 M to 1.3 M (-8.88 %)
Apr 30 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,232	0	124,500
Apr 27 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Hadfield Robert	General Counsel and ...	Option Exercise	A	4.32	150,000	648,000	150,000
Mar 30 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,220	0	123,268
Feb 28 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,208	0	122,048
Jan 31 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,196	0	120,840
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	WEISER MICHAEL	Director	Payment of Exercise	F	4.14	6,021	24,927	224,282	230.3 K to 224.3 K (-2.61 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	WEISER MICHAEL	Director	Grant	A	0.00	17,258	0	230,303	213 K to 230.3 K (+8.10 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Tarriff Scott	Director	Option Exercise	A	4.14	25,000	103,500	25,000
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Payment of Exercise	F	4.14	6,882	28,491	156,446	163.3 K to 156.4 K (-4.21 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Grant	A	0.00	17,258	0	163,328	146.1 K to 163.3 K (+11.81 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	4.14	16,157	66,890	1,389,396	1.4 M to 1.4 M (-1.15 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Payment of Exercise	F	4.14	26,178	108,377	1,405,553	1.4 M to 1.4 M (-1.83 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Grant	A	0.00	348,000	0	1,431,731	1.1 M to 1.4 M (+32.11 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	BELBEL CAESAR J	COO, CLO, and Secre ...	Payment of Exercise	F	4.14	21,667	89,701	207,434	229.1 K to 207.4 K (-9.46 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	BELBEL CAESAR J	COO, CLO, and Secre ...	Payment of Exercise	F	4.14	31,450	130,203	229,101	260.6 K to 229.1 K (-12.07 %)
Jan 03 2018	ZIOP	ZIOPHARM ONCOLOGY ...	BELBEL CAESAR J	COO, CLO, and Secre ...	Grant	A	0.00	87,000	0	260,551	173.6 K to 260.6 K (+50.13 %)
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Option Exercise	M	2.73	20,000	54,600	0
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Payment of Exercise	F	4.17	13,094	54,602	374,408	387.5 K to 374.4 K (-3.38 %)
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Buy	M	2.73	20,000	54,600	387,502	367.5 K to 387.5 K (+5.44 %)
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Option Exercise	M	2.73	20,000	54,600	0
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Payment of Exercise	F	4.20	15,800	66,360	146,070	161.9 K to 146.1 K (-9.76 %)
Dec 13 2017	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Buy	M	2.73	20,000	54,600	161,870	141.9 K to 161.9 K (+14.10 %)
Dec 11 2017	ZIOP	ZIOPHARM ONCOLOGY ...	WEISER MICHAEL	Director	Option Exercise	M	2.73	20,000	54,600	0
Dec 11 2017	ZIOP	ZIOPHARM ONCOLOGY ...	WEISER MICHAEL	Director	Payment of Exercise	F	4.43	12,325	54,600	213,045	225.4 K to 213 K (-5.47 %)
Dec 11 2017	ZIOP	ZIOPHARM ONCOLOGY ...	WEISER MICHAEL	Director	Buy	M	2.73	20,000	54,600	225,370	205.4 K to 225.4 K (+9.74 %)
Nov 30 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,172	0	118,460
Nov 22 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Option Exercise	M	2.73	20,000	54,600	0
Nov 22 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Payment of Exercise	F	4.32	12,639	54,600	62,175	74.8 K to 62.2 K (-16.89 %)
Nov 22 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Buy	M	2.73	20,000	54,600	74,814	54.8 K to 74.8 K (+36.49 %)
Nov 09 2017	ZIOP	ZIOPHARM ONCOLOGY ...	Cooper Laurence James Neil	Chief Executive Off ...	Buy	P	4.68	6,440	30,139	1,083,731	1.1 M to 1.1 M (+0.60 %)
Nov 09 2017	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	EVP and Chief Busin ...	Buy	P	4.68	4,270	19,984	58,662	54.4 K to 58.7 K (+7.85 %)
Nov 01 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,161	0	117,288
Oct 02 2017	ZIOP	ZIOPHARM ONCOLOGY ...	MAUNEY DAVID M MD	EVP and Chief Busin ...	Option Exercise	A	6.19	500,000	3,095,000	500,000
Sep 29 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,149	0	116,127
Aug 31 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,138	0	114,978
Jul 31 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,127	0	113,840
Jun 30 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,115	0	112,713
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Option Exercise	M	4.85	15,000	72,750	0
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Payment of Exercise	F	5.47	13,300	72,751	54,814	68.1 K to 54.8 K (-19.53 %)
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	BRENNAN MURRAY	Director	Buy	M	4.85	15,000	72,750	68,114	53.1 K to 68.1 K (+28.24 %)
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Option Exercise	M	4.85	15,000	72,750	0
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	CANNON JAMES ANTHONY	Director	Buy	M	4.85	15,000	72,750	367,502	352.5 K to 367.5 K (+4.26 %)
Jun 14 2017	ZIOP	ZIOPHARM ONCOLOGY ...	Fowler Wyche	Director	Option Exercise	M	4.85	15,000	72,750	0

Page: 1 2 3 4 4 next >